![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Results of a Phase 1b, Open-label, Multicenter Study of Selgantolimod (GS-9688) in Special Populations of Patients With Chronic Hepatitis B
|
|
|
Results of a Phase 1b, Open-label, Multicenter Study of Selgantolimod (GS-9688) in Special Populations of Patients With Chronic Hepatitis B
![0703231](../images/070323/070323-6/0703231.gif)
![0703232](../images/070323/070323-6/0703232.gif)
![0703233](../images/070323/070323-6/0703233.gif)
![0703234](../images/070323/070323-6/0703234.gif)
![0703235](../images/070323/070323-6/0703235.gif)
![0703236](../images/070323/070323-6/0703236.gif)
![0703237](../images/070323/070323-6/0703237.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|